USPTO serial 79176067
NORDIC NANOVECTOR
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHADAB, SETH WILLIG
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NORDIC NANOVECTOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances, including pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use | SECTION 70 - CANCELLED | — |
| 042 | Medical and pharmaceutical research and development, including medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials, including conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, including in the field of hematology, oncology and the treatment of cancer | SECTION 70 - CANCELLED | — |
| 044 | Medical services; services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 14, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 24, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 8, 2017 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 4, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 4, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 28, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 12, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 12, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 4, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 4, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 12, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 26, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 22, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 5, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 5, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 29, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 28, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 15, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |